Arsenic transport by the human multidrug resistance protein 1 (MRP1/ABCC1) - Evidence that a tri-glutathione conjugate is required

被引:200
作者
Leslie, EM
Haimeur, A
Waalkes, MP
机构
[1] NIEHS, Inorgan Carcinogenesis Sect, Comparat Carcinogenesis Lab, NCI,NIH, Res Triangle Pk, NC 27709 USA
[2] Queens Univ, Canc Res Labs, Kingston, ON K7L 3N6, Canada
关键词
D O I
10.1074/jbc.M404912200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inorganic arsenic is an established human carcinogen, but its metabolism is incompletely defined. The ATP binding cassette protein, multidrug resistance protein (MRP1/ABCC1), transports conjugated organic anions (e.g. leukotriene C-4) and also co-transports certain unmodified xenobiotics ( e. g. vincristine) with glutathione (GSH). MRP1 also confers resistance to arsenic in association with GSH; however, the mechanism and the species of arsenic transported are unknown. Using membrane vesicles prepared from the MRP1-overexpressing lung cancer cell line, H69AR, we found that MRP1 transports arsenite (As-III) only in the presence of GSH but does not transport arsenate (As-V) ( with or without GSH). The non-reducing GSH analogs L-gamma-glutamyl-L-alpha-aminobutyryl glycine and S-methyl GSH did not support AsIII transport, indicating that the free thiol group of GSH is required. GSH-dependent transport of As-III was 2-fold higher at pH 6.5-7 than at a more basic pH, consistent with the formation and transport of the acid-stable arsenic triglutathione (As(GS)(3)). Immunoblot analysis of H69AR vesicles revealed the unexpected membrane association of GSH S-transferase P1-1 (GSTP1-1). Membrane vesicles from an MRP1-transfected HeLa cell line lacking membrane-associated GSTP1-1 did not transport AsIII even in the presence of GSH but did transport synthetic As(GS)(3). The addition of exogenous GSTP1-1 to HeLa-MRP1 vesicles resulted in GSH-dependent AsIII transport. The apparent K-m of As(GS)(3) for MRP1 was 0.32 muM, suggesting a remarkably high relative affinity. As(GS)(3) transport by MRP1 was osmotically sensitive and was inhibited by several conjugated organic anions ( MRP1 substrates) as well as the metalloid antimonite (K-i 2.8 muM). As(GS) 3 transport experiments using MRP1 mutants with substrate specificities differing from wild-type MRP1 suggested a commonality in the substrate binding pockets of As(GS)(3) and leukotriene C-4. Finally, human MRP2 also transported As(GS)(3). In conclusion, MRP1 transports inorganic arsenic as a tri-GSH conjugate, and GSTP1-1 may have a synergistic role in this process.
引用
收藏
页码:32700 / 32708
页数:9
相关论文
共 67 条
[41]   Multidrug resistance protein (MRP)-mediated transport of leukotriene C-4 and chemotherapeutic agents in membrane vesicles - Demonstration of glutathione-dependent vincristine transport [J].
Loe, DW ;
Almquist, KC ;
Deeley, RG ;
Cole, SPC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (16) :9675-9682
[42]   Role of the multidrug resistance protein 1 in protection from heavy metal oxyanions:: Investigations in vitro and in MRP1-deficient mice [J].
Lorico, A ;
Bertola, A ;
Baum, C ;
Fodstad, O ;
Rappa, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 291 (03) :617-622
[43]  
Lorico A, 1997, CANCER RES, V57, P5238
[44]   A physiologically based pharmacokinetic model for arsenic exposure .2. Validation and application in humans [J].
Mann, S ;
Droz, PO ;
Vahter, M .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1996, 140 (02) :471-486
[45]   A physiologically based pharmacokinetic model for arsenic exposure .1. Development in hamsters and rabbits [J].
Mann, S ;
Droz, PO ;
Vahter, M .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1996, 137 (01) :8-22
[46]   ATPase activity of purified and reconstituted multidrug resistance protein MRP1 from drug-selected H69AR cells [J].
Mao, QC ;
Leslie, EM ;
Deeley, RG ;
Cole, SPC .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1999, 1461 (01) :69-82
[47]   Polymorphisms in the human monomethylarsonic acid (MMAV) reductase/hGSTO1 gene and changes in urinary arsenic profiles [J].
Marnell, LL ;
Garcia-Vargas, GG ;
Chowdhury, UK ;
Zakharyan, RA ;
Walsh, B ;
Avram, MD ;
Kopplin, MJ ;
Cebrián, ME ;
Silbergeld, EK ;
Aposhian, HV .
CHEMICAL RESEARCH IN TOXICOLOGY, 2003, 16 (12) :1507-1513
[48]   THE AMOUNT AND NATURE OF GLUTATHIONE TRANSFERASES IN RAT-LIVER MICROSOMES DETERMINED BY IMMUNOCHEMICAL METHODS [J].
MORGENSTERN, R ;
GUTHENBERG, C ;
MANNERVIK, B ;
DEPIERRE, JW .
FEBS LETTERS, 1983, 160 (1-2) :264-268
[49]   Arsenate reduction in human erythrocytes and rats -: Testing the role of purine nucleoside phosphorylase [J].
Németi, B ;
Csanaky, I ;
Gregus, Z .
TOXICOLOGICAL SCIENCES, 2003, 74 (01) :22-31
[50]  
O'Brien ML, 1999, J PHARMACOL EXP THER, V291, P1348